Elekta AB (publ) (STO:EKTA.B)

Market Cap	19.09B
Revenue (ttm)	17.88B
Net Income (ttm)	1.04B
Shares Out	382.08M
EPS (ttm)	2.72
PE Ratio	18.39
Forward PE	12.06
Dividend	2.40 (4.80%)
Ex-Dividend Date	Mar 6, 2025

Volume	948,817
Average Volume	1,328,357
Open	49.60
Previous Close	49.24
Day's Range	49.54 - 50.35
52-Week Range	44.50 - 88.85
Beta	1.08
RSI	49.29
Earnings Date	May 28, 2025

About Elekta AB

Elekta AB (publ), a medical technology company, engages in the provision of clinical solutions for treating cancer and brain disorders worldwide. The company offers radiation therapy products, including Elekta Unity for real-time MR visualization; Elekta Versa HD, a brain metastases solution; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; and quality assurance, and treatment and motion management solutions. It also provides stereotactic radiosurgery products, suc...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1972
• Employees: 4,718
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: EKTA.B

Financial Performance

In 2024, Elekta AB's revenue was 18.12 billion, an increase of 7.41% compared to the previous year's 16.87 billion. Earnings were 1.30 billion, an increase of 38.07%.